Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Tanaka, Tatsuya ^a   Ishiguro, Hideyuki ^a   Kuwabara, Yoshiyuki ^a   Kimura, Masahiro ^a   Mitsui, Akira ^a   Katada, Takeyasu ^a   Shiozaki, Midori ^a   Naganawa, Yasuhiro ^a   Fujii, Yoshitaka ^a   Takeyama, Hiromitsu ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT INDICATION; UNIVARIATE ANALYSIS; CASE CONTROL STUDY; COMPARATIVE STUDY; ESOPHAGUS; ESOPHAGUS TUMOR; GENETICS; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 77953940104     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-83     Document Type: Article

References (28)

1. Aberrations of tumor-suppressor genes (p53, apc, mcc and Rb) in esophageal squamous-cell carcinoma. C Maesawa G Tamura Y Suzuki S Ogasawara K Ishida K Saito R Satodate, Int J Cancer 1994 57 21 25 10.1002/ijc.2910570105 8150536
2. LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. K Dolan J Garde SJ Walker R Sutton J Gosney JK Field, Hum Pathol 1999 30 1508 1514 10.1016/S0046-8177(99)90175-2 10667431
3. Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. T Nishiwaki Y Daigo T Kawasoe Y Nakamura, Genes Chromosomes Cancer 2000 27 169 176 10.1002/(SICI)1098-2264(200002)27:2<169::AID-GCC8>3.0.CO;2-M 10612805
4. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. S Miyake K Nagai K Yoshino M Oto M Endo Y Yuasa, Cancer Res 1994 54 3007 3010 8187090
5. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Y Daigo T Nishiwaki T Kawasoe M Tamari E Tsuchiya Y Nakamura, Cancer Res 1999 59 1966 1972 10213508
6. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases, J Am Coll Surg 2001 192 708 718 10.1016/S1072-7515(01) 00840-7 11400964
7. Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer. A Itami Y Shimada G Watanabe M Imamura, Oncology 1999 57 311 317 10.1159/000012067 10575318
8. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms. RF Souza L Garrigue-Antar J Lei J Yin R Appel VF Vellucci TT Zou X Zhou S Wang MG Rhyu K Cymes O Chan WS Park MJ Krasna BD Greenwald J Cottrell JM Abraham L Simms B Leggett J Young N Harpaz M Reiss SJ Meltzer, Hum Cell 1996 9 229 236 9183654
9. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. K Kawakami J Brabender RV Lord S Groshen BD Greenwald MJ Krasna J Yin AS Fleisher JM Abraham DG Beer D Sidransky HT Huss TR Demeester C Eads PW Laird DH Ilson DP Kelsen D Harpole MB Moore KD Danenberg PV Danenberg SJ Meltzer, J Natl Cancer Inst 2000 92 1805 1811 10.1093/jnci/92.22.1805 11078757
10. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. RF Boynton PL Blount J Yin VL Brown Y Huang Y Tong T McDaniel C Newkirk JH Resau WH Raskind RC Haggitt BJ Reid SJ Meltzer, Proc Natl Acad Sci USA 1992 89 3385 3388 10.1073/pnas.89.8.3385 1565631
11. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. J Kato Y Kuwabara M Mitani N Shinoda A Sato T Toyama A Mitsui T Nishiwaki S Moriyama J Kudo Y Fujii, Int J Cancer 2001 95 92 95 10.1002/1097-0215(20010320)95:2<92::AID-IJC1016>3.0.CO;2-9 11241318
12. Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy. Y Shimada M Imamura I Shibagaki H Tanaka T Miyahara M Kato K Ishizaki, Ann Surg 1997 226 162 168 10.1097/00000658-199708000-00007 9296509
13. From angiogenesis to lymphangiogenesis. K Plate, Nat Med 2001 7 151 152 10.1038/84579 11175837
14. TNM classification of malignant tumor. LH Sobin C Wittekind, New Jersey: John Wiley and Sons six 2002
15. The biology of vascular endothelial growth factor. N Ferrara T Davis-Smyth, Endocr Rev 1997 18 4 25 10.1210/er.18.1.4 9034784
16. The role of the VEGF-C/VEGFR-3 axis in cancer progression. JL Su CJ Yen PS Chen SE Chuang CC Hong IH Kuo HY Chen MC Hung ML Kuo, Br J Cancer 2007 96 541 545 10.1038/sj.bjc.6603487 17164762
17. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. S Juttner C Wissmann T Jons M Vieth J Hertel S Gretschel PM Schlag W Kemmner M Hocker, J Clin Oncol 2006 24 228 240 10.1200/JCO.2004.00.3467 16344322
18. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. PO Van Trappen D Steele DG Lowe S Baithun N Beasley W Thiele H Weich J Krishnan JH Shepherd MS Pepper DG Jackson JP Sleeman IJ Jacobs, J Pathol 2003 201 544 554 10.1002/path.1467 14648657
19. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. D Witte A Thomas N Ali N Carlson M Younes, Anticancer Res 2002 22 1463 1466 12168824
20. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. C Neuchrist BM Erovic A Handisurya MB Fischer GE Steiner D Hollemann C Gedlicka A Saaristo M Burian, Head Neck 2003 25 464 474 10.1002/hed.10235 12784238
21. The expression pattern of vascular endothelial growth factor C and D in human esophageal normal mucosa, dysplasia and neoplasia. M Ishikawa J Kitayama S Kazama H Nagawa, Hepatogastroenterology 2004 51 1319 1322 15362742 (Pubitemid 38987471)
22. Expression of vascular endothelial growth factor-C and angiogenesis in esophageal squamous cell carcinoma. MX Ding XQ Lin XY Fu N Zhang JC Li, World J Gastroenterol 2006 12 4582 4585 16874878 (Pubitemid 44256352)
23. Expression of vascular endothelial growth factor C is a prognostic indicator in esophageal cancer. T Okazawa T Yoshida Y Shirai R Shiraishi T Harada I Sakaida T Abe M Oka, Hepatogastroenterology 2008 55 1503 1508 19102331
24. Nonsurgical treatments for submucosal esophageal squamous cell carcinomas. K Minashi M Muto A Ohtsu, Esophagus 2007 4 159 164 10.1007/s10388-007-0138-4 (Pubitemid 351199268)
25. Diagnostic accuracy of tumor staging and treatment outcomes in patients with superficial esophageal cancer. M Arima H Arima M Tada Y Tanaka, Esophagus 2007 4 145 153 10.1007/s10388-007-0136-6 (Pubitemid 351199266)
26. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. O Pech A May E Gunter L Gossner C Ell, Am J Gastroenterol 2006 101 2223 2229 10.1111/j.1572-0241.2006.00718.x 17032186
27. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. K Kim SJ Park BT Kim KS Lee YM Shim, Ann Thorac Surg 2001 71 290 294 10.1016/S0003-4975(00)02221-9 11216764
28. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. YC Yoon KS Lee YM Shim BT Kim K Kim TS Kim, Radiology 2003 227 764 770 10.1148/radiol.2281020423 12773680